10x Genomics (TXG) Price & Analysis

Compare

1,112 Followers

TXG Stock Chart & Stats

Day’s Range― - ―

52-Week Range$6.78 - $24.76

Previous CloseN/A

Volume385.49K

Average Volume (3M)3.19M

Market Cap

$1.75B

Enterprise Value$1.08B

Total Cash (Recent Filing)$447.26M

Total Debt (Recent Filing)$86.74M

Price to Earnings (P/E)―

Beta1.72

Next Earnings

Oct 29, 2025

EPS Estimate

-0.29

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.28

Shares Outstanding114,411,470

10 Day Avg. Volume3,213,843

30 Day Avg. Volume3,185,399

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.62

Enterprise Value/Revenue1.68

Enterprise Value/Gross Profit2.41

Enterprise Value/Ebitda-19.96

Forecast

1Y Price Target

$14.91

Price Target Upside6.27% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering12

Bulls Say, Bears Say

Bulls Say

Financial Performance10x Genomics reported 2Q25 results that were above estimates and FactSet consensus, showing optimism for reaccelerating growth.

Product AdoptionGrowing placements of Chromium and Single Cell reaction growth on strong adoption of recently launched products plus robust Spatial consumables growth are encouraging signs amidst challenging market environment.

Strategic AcquisitionThe acquisition of Scale Biosciences strengthens 10x Genomics' leadership position in single cell technology.

Bears Say

Budget ConstraintsA significant portion of TXG's revenue comes from the US academic market, which faces budget constraints affecting overall demand.

Macroeconomic EnvironmentThere is continued caution and uncertainty around capital expenditure visibility due to macroeconomic factors and funding.

Revenue Guidance10x Genomics withdrew its full-year guidance due to uncertain macroeconomic conditions and significant exposure to pressured end-markets.

10x Genomics News

Cathie Wood Sells Roku Stock, Doubles Down on Biotech Bets

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made strategic portfolio adjustments on Wednesday, August 20, according to the funds’ daily disclosures....

7d ago

TXG

Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made significant multi-million-dollar trades in the fintech and biotech sectors on Tuesday, August 19,...

8d ago

TXG

WGS

Cathie Wood’s ARK Investment buys 468K shares of 10x Genomics today

20:08 EDT Cathie Wood’s ARK Investment buys 468K shares of 10x Genomics (TXG) today Published first on TheFly...

9d ago

TXG

10x Genomics price target raised to $16 from $15 at Canaccord

Canaccord analyst Kyle Mikson raised the firm’s price target on 10x Genomics (TXG) to $16 from $15 and...

17d ago

TXG

10x Genomics price target raised to $13 from $12 at UBS

UBS analyst Dan Leonard raised the firm’s price target on 10x Genomics (TXG) to $13 from $12 and...

20d ago

TXG

10x Genomics price target raised to $14 from $10 at Deutsche Bank

Deutsche Bank analyst Justin Bowers raised the firm’s price target on 10x Genomics (TXG) to $14 from $10...

20d ago

TXG

10x Genomics price target raised to $15 from $13 at Barclays

Barclays raised the firm’s price target on 10x Genomics (TXG) to $15 from $13 and keeps an Overweight...

20d ago

TXG

10x Genomics to acquire Scale Biosciences, terms not disclosed

10x Genomics (TXG) announced that it has signed a definitive agreement to acquire Scale Biosciences, a company in...

21d ago

TXG

10x Genomics reports Q2 EPS 28c vs (32c) last year

Reports Q2 revenue $172.9M, consensus $139.51M. “The second quarter unfolded largely as anticipated,” said Serge Saxonov, Co-founder and...

21d ago

TXG

10x Genomics sees Q3 revenue $140M-$144M, consensus $144.53M

10x Genomics (TXG) expects third quarter 2025 revenue to be in the range of $140 million to $144...

21d ago

TXG

10X Genomics Balances Growth and Challenges in Earnings Call

10X Genomics (($TXG)) has held its Q2 earnings call. Read on for the main highlights of the call....

16d ago

TXG

Promising Growth and Strategic Positioning: Yuko Oku’s Buy Rating on 10x Genomics

Morgan Stanley analyst Yuko Oku has maintained their bullish stance on TXG stock, giving a Buy rating yesterday....

16d ago

TXG

10x Genomics Positioned for Growth: Strong Q2 Results, Strategic Acquisition, and Optimistic Outlook Drive Buy Rating

Kyle Mikson CFA, an analyst from Canaccord Genuity, maintained the Buy rating on 10x Genomics. The associated price...

20d ago

TXG

10x Genomics: Balanced Outlook Amid Growth and Uncertainties

William Blair analyst Matt Larew has maintained their neutral stance on TXG stock, giving a Hold rating yesterday....

20d ago

TXG

TXG FAQ

What was 10x Genomics Inc’s price range in the past 12 months?

10x Genomics Inc lowest stock price was $6.78 and its highest was $24.76 in the past 12 months.

What is 10x Genomics Inc’s market cap?

10x Genomics Inc’s market cap is $1.75B.

When is 10x Genomics Inc’s upcoming earnings report date?

10x Genomics Inc’s upcoming earnings report date is Oct 29, 2025 which is in 62 days.

How were 10x Genomics Inc’s earnings last quarter?

10x Genomics Inc released its earnings results on Aug 07, 2025. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of -$0.37 by $0.65.

Is 10x Genomics Inc overvalued?

According to Wall Street analysts 10x Genomics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does 10x Genomics Inc pay dividends?

10x Genomics Inc does not currently pay dividends.

What is 10x Genomics Inc’s EPS estimate?

10x Genomics Inc’s EPS estimate is -0.29.

How many shares outstanding does 10x Genomics Inc have?

10x Genomics Inc has 114,411,470 shares outstanding.

What happened to 10x Genomics Inc’s price movement after its last earnings report?

10x Genomics Inc reported an EPS of $0.28 in its last earnings report, beating expectations of -$0.37. Following the earnings report the stock price went down -3.984%.

Which hedge fund is a major shareholder of 10x Genomics Inc?

Currently, no hedge funds are holding shares in TXG

10x Genomics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-11.30%

Trailing 12-Months

Asset Growth

5.41%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

10x Genomics Inc

10x Genomics (TXG) is a biotechnology company specializing in genomic sequencing and analysis technologies that enable researchers to gain insights into complex biological systems. Founded in 2012 and headquartered in Pleasanton, California, the company operates primarily in the life sciences sector. Its core products include the Chromium System, which allows for high-throughput single-cell sequencing, and various reagents and software solutions designed for applications in genomics, transcriptomics, and epigenomics. 10x Genomics serves a diverse customer base including academic institutions, pharmaceutical companies, and biotechnology firms, facilitating advancements in precision medicine and personalized therapeutics.

10x Genomics (TXG) Earnings & Revenues

Historic Earnings Reports

TXG Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted a mix of positive developments, such as a favorable litigation settlement and growth in spatial consumables, alongside challenges like declining instrument revenue and a difficult funding environment. While there are areas of growth and strategic advancements, the ongoing challenges in the academic and CapEx environment present significant hurdles.View all TXG earnings summaries

TXG Revenue Breakdown

60.32% Americas

22.99% EMEA

8.45% Asia-Pacific excluding China

8.24% China

TXG Stock 12 Month Forecast

Average Price Target

$14.91

▲(6.27% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","24":"$24","11.25":"$11.25","15.5":"$15.5","19.75":"$19.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,11.25,15.5,19.75,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.08,13.381538461538462,13.683076923076923,13.984615384615385,14.286153846153846,14.587692307692308,14.88923076923077,15.19076923076923,15.492307692307692,15.793846153846154,16.095384615384617,16.396923076923077,16.698461538461537,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.08,13.22076923076923,13.361538461538462,13.502307692307692,13.643076923076924,13.783846153846154,13.924615384615384,14.065384615384616,14.206153846153846,14.346923076923076,14.487692307692308,14.628461538461538,14.76923076923077,{"y":14.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.08,13.073846153846153,13.067692307692308,13.061538461538461,13.055384615384616,13.04923076923077,13.043076923076923,13.036923076923078,13.03076923076923,13.024615384615384,13.018461538461539,13.012307692307692,13.006153846153847,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.68,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.35,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.31,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.47,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.36,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.69,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.67,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.06,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >